• Short-term goals are to safely achieve reduction in BP through the iterative process of employing drug therapy, along with nondrug therapy or lifestyle changes.
• Lifestyle changes should address other risk factors for CVD including obesity, physical inactivity, insulin resistance, dyslipidemia, smoking cessation, and others.
• Monitoring for efficacy, adverse events, and adherence to therapy is key to achieving the long-term goals of reducing the risk of morbidity and mortality associated with CVD.
Abbreviations Introduced in This Chapter
American College of Card iology/ American Heart Association Avoiding Cardiovascular Hvcnts in Combination Therapy in Patients Living with Systolic Hypertension Angiotensin-converting enzyme Angiotensin-Converting enzyme inhibitor
African American Heart Failure trial Acute Infarction Ramipril Efficacy Study
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Acute myocardial infarction Australian-New Zealand Blood Pressure-2 study Angiotensin-receptor blocker Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm study Angiotcnsin-1 Angiotensin-2
/^-Blocker Heart Attack Trial Blood urea nitrogen Chymostatin-sensitive II-generating enzyme
Was this article helpful?
Your heart pumps blood throughout your body using a network of tubing called arteries and capillaries which return the blood back to your heart via your veins. Blood pressure is the force of the blood pushing against the walls of your arteries as your heart beats.Learn more...